231
Participants
Start Date
June 30, 2012
Primary Completion Date
January 31, 2015
Study Completion Date
July 31, 2016
Percutaneous coronary intervention
Up to 140 patients meeting the inclusion criteria and none of the exclusion criteria are randomly selected and stratified according to diabetic status at screening are treated with the Pantera Lux drug coated balloon.
Percutaneous coronary intervention
Up to 70 patients meeting the inclusion criteria and none of the exclusion criteria are randomly selected and stratified according to diabetic status at screening are treated with the Orsiro drug eluting stent.
Charité - Universitätsmedizin Berlin, Charité Centrum 11 für Herz-, Kreislauf- und Gefäßmedizin, Berlin
Innere Medizin Kardiologie - Charité Centrum 11, Campus Benjamin Franklin, Berlin
Medical Care Center Prof. Mathey, Prof. Schofer, Hamburg
Heart Center Segeberger Kliniken, Bad Segeberg
Kardiologie /Intern. Intensivmedizin, Johannes Wesling Klinikum Minden, Minden
Contilia Heart- and Vascular Center, Elisabeth Krankenhaus, Essen
Universitätsklinikum Münster, Klinik für Kardiologie, Münster
Innere Medizin III Kardiologie, Kliniken Villingen, Villingen-Schwenningen
Universitäts-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen
Klinikum Schwabing, Munich
LMU - Klinikum der Universität München, Munich
Klinikum Bogenhausen, Munich
Kardiologie - Angiologie - Pneumologie, Klinikum Coburg, Coburg
Cardiology, Pauls Stradins Clinical University Hospital, Riga
Lead Sponsor
Biotronik AG
INDUSTRY